NCT06508671
- Conditions
- Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, +5 more
- Locations
-
Not specified
Clinical trial condition
DL-3-n-butylphthalide
Explore clinical trials studying DL-3-n-butylphthalide. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies